Gemini Space Station Rises, Oracle Slumps, Eli Lilly Rises on Experimental Shot Cutting Weight

On this episode of Stock Movers:
- Gemini Space Station (GEMI) shares rise after the crypto exchange founded by the Winklevoss twins said it received a Designated Contract Market license from the Commodity Futures Trading Commission, allowing Gemini to offer prediction markets in the US.
- Oracle (ORCL) Shares slump after the company forecast 3Q cloud sales growth below analyst estimates, raising concerns that supply constraints are preventing the cloud infrastructure provider from converting its large backlog to actual revenues.
- Eli Lilly (LLY) shares rise after a next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet.

See omnystudio.com/listener for privacy information.